HB 772 establishes a workgroup within Maryland's Health Care Commission to develop fairer reimbursement methods for certified community behavioral health clinics and outpatient mental health centers. The workgroup will study current costs, staffing models, and federal requirements to create transparent, cost-based payment systems, comparing approaches used in other states. It must submit an interim report by December 2026 and a final report by October 2027 with specific recommendations, implementation options, and fiscal estimates. The bill does not require immediate rate changes or new funding, but rather sets a process for future policy decisions based on the workgroup's findings.
HB 1533 (the Crown and Care Act) bans 12 specific harmful ingredients - including certain phthalates, formaldehyde, mercury, and PFAS chemicals - from cosmetic products sold in Maryland. It directly affects cosmetic manufacturers, retailers, and salons by prohibiting the sale or distribution of products containing these ingredients, with limited exceptions for unavoidable trace amounts from manufacturing processes. The bill authorizes the Maryland Department of Health to investigate complaints, inspect businesses, and enforce penalties, while allowing consumers harmed by violations to seek civil damages and attorney fees. This law aims to protect public health by reducing exposure to chemicals linked to health risks like skin irritation and potential long-term harm.
HB 1135 allows pharmacists in Maryland to order certain vaccinations for patients aged 3 and older without needing to administer the vaccine themselves. Pharmacists must complete 20+ hours of approved training covering vaccine safety, injection techniques, and emergency response, hold current CPR certification, and report all vaccinations to the ImmuNet program. The bill specifically covers influenza, COVID-19, and emergency-use vaccines, and requires pharmacists to refer minors to pediatric care when ordering vaccines. This expands pharmacists' role in vaccine access while maintaining safety protocols and reporting requirements.
SB 773 allows pharmacists in Maryland to order certain vaccinations (like flu, COVID-19, or emergency vaccines) for patients aged 3 and older without needing to administer the vaccine themselves. To qualify, pharmacists must complete 20 hours of approved training, hold current CPR certification, and complete 2 hours of continuing education on immunizations. The bill requires pharmacists to follow written vaccine-specific protocols, report all vaccinations to Maryland’s ImmuNet registry, and refer pediatric patients to primary care providers when appropriate. This policy directly affects pharmacists, patients seeking these vaccines, and healthcare coordination for immunizations. The changes take effect October 1, 2026.
SB 778 creates a new "clinical research pharmacy permit" required for pharmacies conducting clinical trials in Maryland. It allows healthcare providers to own such pharmacies under specific conditions, including requiring a licensed pharmacist to be on-site at all times and prohibiting owners from receiving payment for patient referrals. The bill also exempts clinical trials conducted by corporations from being classified as "practice of medicine," removing a licensing barrier for these activities. This directly affects pharmacies seeking to operate clinical trials, healthcare providers considering ownership, and the State Board of Pharmacy (as the permit issuer).
HB 347 adds hypertension to the list of occupational diseases presumed work-related for specific emergency responders in Maryland. It creates a legal presumption that firefighters, firefighting instructors, rescue squad members, advanced life support unit members, and State Fire Marshal staff with hypertension are entitled to workers' compensation benefits if they meet four conditions: diagnosed by a provider, prescribed hypertension medication for 90+ consecutive days, completed 2+ years of cumulative service in the state, and are currently employed in that role. This bill modifies Maryland’s workers’ compensation law (specifically Sections 9-502 and 9-503) to expand eligibility for these occupations without requiring separate proof that hypertension resulted from their job duties. It directly affects these emergency personnel seeking compensation for hypertension-related disability or death.
HB 374 revises Maryland's acupuncture licensing rules to clarify that "manual therapies" (like acupressure) are included under licensed acupuncture practice. It requires the State Acupuncture Board to provide proof of license renewal instead of issuing physical renewal certificates. The bill also explicitly prohibits employers from hiring unlicensed practitioners and bans aiding or abetting unauthorized acupuncture practice. These changes directly affect licensed acupuncturists, their employers, and individuals seeking acupuncture services in Maryland. The revisions aim to modernize licensing procedures while strengthening enforcement against unlicensed activity.
SB 370 revises Maryland's acupuncture licensing rules by defining "manual therapies" as part of licensed acupuncture practice and requiring the State Acupuncture Board to provide proof of license renewal instead of issuing physical renewal certificates. The bill prohibits employers from hiring unlicensed acupuncture practitioners or aiding unauthorized practice, with penalties including civil fines up to $50,000 and criminal charges for repeat offenses. It directly affects licensed acupuncturists, their employers, and clinics that hire practitioners, clarifying what constitutes authorized practice under state law. The changes take effect October 1, 2026, and align licensing standards with national certification requirements for new applicants.
SB 39 establishes a workgroup to develop a sustainable reimbursement rate methodology for Maryland's Certified Community Behavioral Health Clinics (CCBHCs) and Outpatient Mental Health Centers (OMHCs), directly affecting behavioral health providers facing financial strain due to outdated rates. The bill requires the Maryland Department of Health to conduct a cost study of OMHC services, form an advisory panel to review rate recommendations, and increase Medicaid reimbursement rates for OMHCs in fiscal years 2026 and 2027. Key provisions include evaluating provider costs, workforce needs, and alignment with somatic health care parity, while addressing closures like those in Frederick County. The workgroup must report findings by December 2027, aiming to stabilize provider finances and ensure continued access to community mental health care.
HB 595 modifies Maryland's income tax credit for physicians mentoring medical students in underserved areas. It removes a requirement that students must be enrolled in a Maryland medical school or training program and reduces the required hours per preceptor rotation from 100 to 90 for community-based clinical training. Licensed physicians serving as preceptors in designated healthcare shortage areas may claim a $1,000 tax credit per qualifying student rotation, capped at $10,000 annually per physician and $100,000 statewide. The bill aims to expand access to physician mentorship by broadening eligibility for the credit, directly benefiting doctors and medical training programs in regions facing healthcare workforce shortages.